Literature DB >> 4109501

Adrenal corticosteroid therapy in far-advanced cancer.

H W Schell.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4109501

Source DB:  PubMed          Journal:  Geriatrics        ISSN: 0016-867X


× No keyword cloud information.
  8 in total

1.  Factors involved in gastrointestinal bleeding in advanced cancer patients followed at home.

Authors:  Sebastiano Mercadante; Flavio Fusco; Alessandro Valle; Fabio Fulfaro; Alessandra Casuccio; Stefania Silvestro; Emanuela Donelli
Journal:  Support Care Cancer       Date:  2003-12-12       Impact factor: 3.603

2.  High-dose corticosteroids for the management of dyspnea in patients with tumor obstruction of the upper airway.

Authors:  Ahmed Elsayem; Eduardo Bruera
Journal:  Support Care Cancer       Date:  2007-07-17       Impact factor: 3.603

3.  [Not Available].

Authors:  M Tryba
Journal:  Schmerz       Date:  1992-03       Impact factor: 1.107

Review 4.  Chronic opioid therapy in long-term cancer survivors.

Authors:  A Carmona-Bayonas; P Jiménez-Fonseca; E Castañón; A Ramchandani-Vaswani; R Sánchez-Bayona; A Custodio; D Calvo-Temprano; J A Virizuela
Journal:  Clin Transl Oncol       Date:  2016-07-21       Impact factor: 3.405

5.  Corticosteroids in terminal cancer--a prospective analysis of current practice.

Authors:  G W Hanks; T Trueman; R G Twycross
Journal:  Postgrad Med J       Date:  1983-11       Impact factor: 2.401

Review 6.  Is the pharmacological treatment of cancer cachexia possible?

Authors:  E Bruera
Journal:  Support Care Cancer       Date:  1993-11       Impact factor: 3.603

7.  [Pharmacotherapy of cancer pain. 3. Adjuvant drugs.].

Authors:  N I Cherny; R K Portenoy; M Raber; M Zenz
Journal:  Schmerz       Date:  1995-03       Impact factor: 1.107

8.  Intrathecal betamethasone for cancer pain: A study of its analgesic efficacy and safety.

Authors:  Hitoshi Taguchi; Keiko Oishi; Koh Shingu; Hideo Matsumoto; Munehiro Masuzawa
Journal:  Acta Anaesthesiol Scand       Date:  2018-12-07       Impact factor: 2.105

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.